Myriad mostly vindicated – for now
The Federal Circuit ruled today in Association for Molecular Pathology v the USPTO and Myriad Genetics that isolated DNA sequences are patent eligible, setting the stage for a Supreme Court battle over gene patents
The court found that only one of the 20 plaintiffs named in the suit had standing to bring the case against Myriad. Many feared the case might...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.